| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Radiation Oncology and the Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322
Genetic and epigenetic alterations affecting proteins involved in
apoptosis can contribute to the establishment and progression of
cancer. Recently, our laboratory has isolated a novel gene,
TMS1, that is aberrantly methylated and silenced
in a significant proportion of human breast cancers. TMS1 contains a
caspase recruitment domain (CARD), suggesting a role in
caspase-mediated cell death. In the present study, we characterize the
participation of TMS1 in apoptosis and examine the subcellular
localization of the protein. Inducible expression of TMS1 inhibited
cellular proliferation and induced DNA fragmentation in a
time-dependent manner. These apoptotic events were blocked by the
general caspase inhibitor, Z-VAD-fmk. The ability of TMS1 to
trigger apoptosis was also suppressed by a dominant negative form
of caspase-9 but not by a dominant negative form of caspase-8,
indicating that TMS1 functions through activation of caspase-9. Unlike
a number of other CARD-containing proteins, TMS1 did not activate
nuclear factor
B-dependent transcription, consistent with a
proapoptotic role for TMS1 in death signaling pathways. Timed
localization studies revealed that TMS1-induced apoptosis was
accompanied by the redistribution of TMS1 from the cytoplasm to
perinuclear spherical structures. Whereas the apoptotic activity of
TMS1 was blocked by caspase inhibition, the formation of
TMS1-containing subcellular structures was not, suggesting that the
redistribution of TMS1 precedes caspase activation. Both the
proapoptotic activity of TMS1 and aggregate formation were dependent on
the CARD. In summary, the data indicate that TMS1-induced apoptosis
proceeds through a CARD-dependent aggregation step followed by
activation of a caspase-9-mediated pathway.
This article has been cited by other articles:
![]() |
E. de Alba Structure and Interdomain Dynamics of Apoptosis-associated Speck-like Protein Containing a CARD (ASC) J. Biol. Chem., November 20, 2009; 284(47): 32932 - 32941. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. GORDIAN, K. RAMACHANDRAN, and R. SINGAL Methylation Mediated Silencing of TMS1 in Breast Cancer and its Potential Contribution to Docetaxel Cytotoxicity Anticancer Res, August 1, 2009; 29(8): 3207 - 3210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Parsons, P. Patel, D. J. Brat, L. Colbert, and P. M. Vertino Silencing of TMS1/ASC Promotes Resistance to Anoikis in Breast Epithelial Cells Cancer Res., March 1, 2009; 69(5): 1706 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T.-H. Huang, D. J. Taxman, E. A. Holley-Guthrie, C. B. Moore, S. B. Willingham, V. Madden, R. K. Parsons, G. L. Featherstone, R. R. Arnold, B. P. O'Connor, et al. Critical Role of Apoptotic Speck Protein Containing a Caspase Recruitment Domain (ASC) and NLRP3 in Causing Necrosis and ASC Speck Formation Induced by Porphyromonas gingivalis in Human Cells J. Immunol., February 15, 2009; 182(4): 2395 - 2404. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kapoor-Vazirani, J. D. Kagey, D. R. Powell, and P. M. Vertino Role of hMOF-Dependent Histone H4 Lysine 16 Acetylation in the Maintenance of TMS1/ASC Gene Activity Cancer Res., August 15, 2008; 68(16): 6810 - 6821. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yajima, M. Takahashi, H. Morimoto, Y. Shiba, Y. Takahashi, J. Masumoto, H. Ise, J. Sagara, J. Nakayama, S. Taniguchi, et al. Critical Role of Bone Marrow Apoptosis-Associated Speck-Like Protein, an Inflammasome Adaptor Molecule, in Neointimal Formation After Vascular Injury in Mice Circulation, June 17, 2008; 117(24): 3079 - 3087. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Machida, M. V. Brock, C. M. Hooker, J. Nakayama, A. Ishida, J. Amano, M. A. Picchi, S. A. Belinsky, J. G. Herman, S. Taniguchi, et al. Hypermethylation of ASC/TMS1 Is a Sputum Marker for Late-Stage Lung Cancer. Cancer Res., June 15, 2006; 66(12): 6210 - 6218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkar, M. Duncan, J. Hart, E. Hertlein, D. C. Guttridge, and M. D. Wewers ASC Directs NF-{kappa}B Activation by Regulating Receptor Interacting Protein-2 (RIP2) Caspase-1 Interactions. J. Immunol., April 15, 2006; 176(8): 4979 - 4986. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Kaiser and M. K. Offermann Apoptosis Induced by the Toll-Like Receptor Adaptor TRIF Is Dependent on Its Receptor Interacting Protein Homotypic Interaction Motif J. Immunol., April 15, 2005; 174(8): 4942 - 4952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, K. Yaginuma, H. Tsutsui, J. Sagara, X. Guan, E. Seki, K. Yasuda, M. Yamamoto, S. Akira, K. Nakanishi, et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules Genes Cells, November 1, 2004; 9(11): 1055 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stehlik and J. C. Reed The PYRIN Connection: Novel Players in Innate Immunity and Inflammation J. Exp. Med., September 7, 2004; 200(5): 551 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kubo, J. Yamamoto, Y. Shikauchi, Y. Niwa, K. Matsubara, and H. Yoshikawa Apoptotic Speck Protein-Like, a Highly Homologous Protein to Apoptotic Speck Protein in the Pyrin Domain, Is Silenced by DNA Methylation and Induces Apoptosis in Human Hepatocellular Carcinoma Cancer Res., August 1, 2004; 64(15): 5172 - 5177. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Terasawa, S. Sagae, M. Toyota, K. Tsukada, K. Ogi, A. Satoh, H. Mita, K. Imai, T. Tokino, and R. Kudo Epigenetic Inactivation of TMS1/ASC in Ovarian Cancer Clin. Cancer Res., March 15, 2004; 10(6): 2000 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garcia-Domingo, D. Ramirez, G. Gonzalez de Buitrago, and C. Martinez-A Death Inducer-Obliterator 1 Triggers Apoptosis after Nuclear Translocation and Caspase Upregulation Mol. Cell. Biol., May 1, 2003; 23(9): 3216 - 3225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stehlik, L. Fiorentino, A. Dorfleutner, J.-M. Bruey, E. M. Ariza, J. Sagara, and J. C. Reed The PAAD/PYRIN-Family Protein ASC Is a Dual Regulator of a Conserved Step in Nuclear Factor {kappa}B Activation Pathways J. Exp. Med., December 16, 2002; 196(12): 1605 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Stimson and P. M. Vertino Methylation-mediated Silencing of TMS1/ASC Is Accompanied by Histone Hypoacetylation and CpG Island-localized Changes in Chromatin Architecture J. Biol. Chem., February 8, 2002; 277(7): 4951 - 4958. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Richards, P. Schaner, A. Diaz, J. Stuckey, E. Shelden, A. Wadhwa, and D. L. Gumucio Interaction between Pyrin and the Apoptotic Speck Protein (ASC) Modulates ASC-induced Apoptosis J. Biol. Chem., October 12, 2001; 276(42): 39320 - 39329. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Masumoto, S.'i. Taniguchi, J. Nakayama, M. Shiohara, E. Hidaka, T. Katsuyama, S. Murase, and J. Sagara Expression of Apoptosis-associated Speck-like Protein Containing a Caspase Recruitment Domain, a Pyrin N-terminal Homology Domain-containing Protein, in Normal Human Tissues J. Histochem. Cytochem., October 1, 2001; 49(10): 1269 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F Costello and C. Plass Methylation matters J. Med. Genet., May 1, 2001; 38(5): 285 - 303. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |